History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

 

Darin Ingels, ND - LDN and Children (2017 Conference) (LDN, low dose naltrexone)

Research on LDN in children shows it is safe with low side effects. Studies where LDN was used successfully in children: 2 with Crohn’s, 2 with autism, 1 with CRPS. His cases: autism; Hashimoto’s; IBS.

 

Stephen Dickson, BSC (hons) MRPharmS - Using an Old Drug to Trick the Immune System into Healing Itself (2018 Conference) (LDN, low dose naltrexone)

 

John Bardsley - Using unlicensed medicines as a part of patient care (2018 Conference) (LDN, low dose naltrexone)

John Bardsley is a pharmacist who has spent 15 years in the supply chain managing small to medium sized businesses in terms of GMP manufacture and GDP distribution throughout the UK. 

 

Olga Cortez, MD - LDN Use in Women's Health I (2019 Conference) (LDN, low dose naltrexone)

 

Nasha Winters, ND - Using LDN to Quell the Over-Reactive Autoimmune Conditions Triggered by Many of Today's Cancer Drugs (2019 Conference) (LDN, low dose naltrexone)

 


Dr Akbar Khan's LDN 2019 Conference Presentation

Low Dose Naltrexone (LDN) vs. Chemotherapy: One “Unproven” Therapy Against Another?

Terry Wingo - LDN Specialist, LDN Radio Show 20 April 2021 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Terry Wingo graduated from Auburn University in 1975 with a bachelor of science in Pharmacy. He has fellowships with the American College of Apothecaries and the American College of Veterinary Pharmacists.